海翔药业 (002099.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(海翔药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 528,463,890.642,171,886,869.451,676,630,297.771,196,440,659.01634,047,833.602,704,144,046.052,071,095,203.001,467,811,588.79804,527,527.52
 营业利润(元) 29,008,301.78-464,242,714.00-44,358,035.4417,897,795.9844,299,883.65109,398,963.01236,009,387.56197,330,525.30100,188,209.80
 利润总额(元) 29,828,645.74-466,223,077.05-45,728,314.2917,046,946.9244,070,550.66100,803,110.15235,901,114.77198,299,402.77100,841,419.77
 净利润(元) 32,097,804.14-421,581,052.88-39,479,339.5118,438,691.2341,848,946.5086,078,081.06205,921,903.88170,799,094.7386,547,687.52
 归属于母公司股东的净利润(元) 32,593,338.56-420,055,857.71-38,588,053.7119,171,880.2942,101,946.6188,013,729.03207,115,696.16171,661,199.9587,024,150.17
盈利能力:
 销售毛利率(%) 31.4914.0319.3620.2520.0326.6429.3930.5829.98
 销售净利率(%) 6.07-19.41-2.351.546.603.189.9411.6410.76
 净资产收益率(%) 0.56-7.17-0.630.310.68----
 总资产报酬率ROA(%) 0.19-6.25-1.17-0.460.81----
 投入资本回报率ROIC(%) 0.48-5.92-0.510.250.541.202.722.301.20
营运能力:
 存货周转率(次) 0.432.071.330.920.51----
 应收账款周转率(次) 1.034.703.672.261.12----
 总资产周转率(次) 0.060.270.200.140.07----
偿债能力:
 资产负债率(%) 27.6325.5129.5530.5532.1527.2628.1826.7022.18
 股东权益比率(%) 72.4374.5570.5069.5067.8972.7771.8573.3277.85
 已获利息倍数(倍) -1.1715.891.840.702.770.02-0.67-2.3827.18
 流动比率 1.491.451.501.491.481.651.561.612.16
 速动比率 1.131.051.041.041.071.071.071.101.54
发展能力:
 营业收入增长率(%) -16.65-19.68-19.05-18.49-21.198.8315.6323.4625.26
 营业利润增长率(%) -34.52-524.36-118.80-90.93-55.78-10.36149.57173.1840.93
 税后利润增长率(%) -22.58-577.26-118.63-88.83-51.62-7.58170.17183.7152.17
 净资产增长率(%) -9.89-8.21-3.67-1.88-1.14-0.112.502.824.28
 总资产增长率(%) -15.55-10.40-1.823.5213.364.6510.188.946.30

前瞻产业研究院